Cargando…
Antithrombin concentrates may benefit cardiopulmonary bypass patients with suspected heparin resistance: A retrospective analysis of real-world data
BACKGROUND: Heparin resistance is a common complication of surgical patients requiring anticoagulation, such as those undergoing cardiopulmonary bypass (CPB). Treatments to address heparin resistance include supplementation of antithrombin (AT) or fresh frozen plasma (FFP). This retrospective databa...
Autores principales: | Bader, Stephen O., Marinaro, Xavier F., Stone, Glenda, Lodaya, Kunal, Spears, Jeffrey B., Shander, Aryeh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10558716/ https://www.ncbi.nlm.nih.gov/pubmed/37809512 http://dx.doi.org/10.1016/j.heliyon.2023.e19497 |
Ejemplares similares
-
Lepirudin as an alternative to "heparin allergy" during cardiopulmonary bypass
por: Parissis, Haralabos
Publicado: (2011) -
Bivalirudin for cardiopulmonary bypass in a patient with heparin allergy
por: Boysan, Emre, et al.
Publicado: (2023) -
How to Solve the Conundrum of Heparin-Induced Thrombocytopenia during Cardiopulmonary Bypass
por: Revelly, Etienne, et al.
Publicado: (2023) -
Successful use of an antithrombin for heparin resistance with andexanet alfa
por: Honda, Jun, et al.
Publicado: (2023) -
Heparin Resistance During Cardiopulmonary Bypass in Adult Cardiac Surgery
por: Chen, Yufan, et al.
Publicado: (2022)